← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 1998Last known activity
Dec 31, 2019
Timeline
1940s
- Jan 1, 1946
Leukemia Research Foundation— Founded
Drugs by trial phase (22 distinct, 7 trials)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Hematologic Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, B-Cell
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Syndrome
Recent trials (7)
- NCT04214886CollaboratorPhase 1Dec 31, 2019
- NCT01617226CollaboratorPhase 2Sep 1, 2012
- NCT01127542CollaboratorPhase 2May 1, 2010
- NCT01334060CollaboratorPhase 2Feb 1, 2010
- NCT00718250CollaboratorPhase 1May 1, 2008
- NCT00004218Lead sponsorPhase 3Oct 1, 1999
- NCT00005823Lead sponsorPhase 3Dec 1, 1998
Details
- Founded
- Northfield, IL, US Jan 1, 1946
- Last known activity
- Dec 31, 2019